Ownership history in ALGERT GLOBAL LLC · 9 quarters on record
This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in ACLARIS THERAPEUTICS INC (ACRS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 65,630 | +25,780 | +64.7% | 0.00% | $125K | $1.90 |
| 2025 Q2 | UNCHANGED | 39,850 | — | 0% | 0.00% | $57K | $1.42 |
| 2025 Q1 | ADDED | 39,850 | +20,080 | +101.6% | 0.00% | $61K | $1.53 |
| 2024 Q3 | ADDED | 19,770 | +7,990 | +67.8% | 0.00% | $23K | $1.15 |
| 2024 Q2 | REDUCED | 11,780 | -4,021 | -25.4% | 0.00% | $13K | $1.10 |
| 2024 Q1 | REDUCED | 15,801 | -29,319 | -65.0% | 0.00% | $20K | $1.24 |
| 2023 Q3 | ADDED | 45,120 | +29,976 | +197.9% | 0.01% | $309K | $6.85 |
| 2023 Q1 | ADDED | 15,144 | +1,314 | +9.5% | 0.01% | $123K | $8.09 |
| 2022 Q4 | INITIATED | 13,830 | — | — | 0.01% | $218K | — |
As of 2025 Q4 — sorted by position size